Is Preoperative Bone Scintigraphy in Early Stage of Breast Cancer Is Preoperative Bone Scintigraphy in Early Stage of Breast Cancer Is preoperative bone scintigraphy in early stage of breast cancer T1N0 Indicated and Meaningful?
Abstract
In the Czech Republic bone scintigraphy has still been performed routinely as a part of preoperative staging examinations of early breast carcinomas, which had been in 42% diagnosed in the national breast cancer screening program. The incidence of synchronnous distant metastases was analysed for a subgroup of T1N0 breast carcinomas using the database of the Czech National Cancer Registry.
Out of 21,675 women with T1N0 breast carcinomas diagnosed in the decade of 2001–2010 the potential occurence of various distant metastases (M1) was estimated in 147 cases (0,68%). Since only approximately 40% of all distant metastases were skeletal (M1 OSS), the probability of bone metastases in T1N0 breast cancer does not exceed 0,3–0,4%.
Distant metastases were present in 0,5% in a subgroup of well and moderately differentiated carcinomas and up to 1,2% in poorly differentiated and anaplastic tumors, however, only a minor part (0,2% and 0,5%, respectively) involved bones. We conclude that preoperative bone scintigraphy is overused and undue in more than 99% of Czech women with early breast cancer T1N0.
Skeletal scintigraphy as a staging procedure for small breast carcinoma T1N0 may perhaps be recommended only postoperatively and very selectively with regards to individual risk factors and symptomatology.